Link: http://www.thewileyprotocol.com
A University of Rochester Medical Center study concluded that the risk of developing breast cancer due to taking hormone replacement therapy appears to be the same for women with a family history of the disease and without a family history.
Epidemiology pubished the study, which focuses on what factors boost breast cancer risk among postmenopausal women.
Interestingly, the study also refutes the notion that a familial predisposition to breast cancer enhances the carcinogenic effects of estrogen, something many people in the medical community have long believed.
You can also find information on the Wiley Protocol website reviewing other research, news and information about the relationship between hormone replacement therapy, cancer, and heart disease. http://www.thewileyprotocol.com/content/view/355/276/
Publicly available data from the WHI trial in addition to support from the National Heart Lung and Blood Institute is how the study was conducted.
Read more on this topic in the Science Daily.
XML Feeds
Recent comments